Get the latest news, insights, and market updates on EW (Edwards Lifesciences Corporation). Explore the news page 4 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
IRVINE, Calif., February 03, 2026--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2025 after the market closes on Tuesday, February 10, and will host a conference call at 5:00 p.m. ET that day to discuss those results. Feb 3, 2026 - $EW
Edwards Lifesciences Corporation (EW): A Bull Case Theory
We came across a bullish thesis on Edwards Lifesciences Corporation on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on EW. Edwards Lifesciences Corporation’s share was trading at $81.49 as of January 29th. EW’s trailing and forward P/E were 35.90 and 28.82 respectively according to Yahoo Finance. Edwards Lifesciences Corporation provides products and […] Feb 3, 2026 - $EW
Edwards Lifesciences Refocuses On Core TAVR And Mitral Growth Story
Edwards Lifesciences (NYSE:EW) is ending its planned acquisition of JenaValve. The company is redirecting the capital that would have gone to the deal into its internal transcatheter aortic valve replacement (TAVR) and mitral valve programs. This move reflects a shift toward developing in house platforms instead of expanding through this external transaction. Edwards Lifesciences is a major player in structural heart therapies, with TAVR and mitral valve technologies at the center of its... Feb 2, 2026 - $EW
Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW)
Edwards Lifesciences Corporation (NYSE:EW) is one of the best healthcare stocks to buy for 2026. On January 20, Stifel raised its price target of Edwards Lifesciences Corporation (NYSE:EW) to $110 from $105 while reiterating a Buy rating. The price target hike is in response to a significant increase in the number of Transcatheter Aortic Valve […] Jan 31, 2026 - $EW
Renewed Growth Cycle Drives a Favorable Sentiment Towards Edwards Lifesciences (EW)
Edwards Lifesciences (NYSE:EW) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On January 20, Adam Maeder from Piper Sandler maintained his Overweight rating on Edwards Lifesciences (NYSE:EW). The analyst also adjusted his price target on the stock from $95 to $98, which now yields almost 20% upside. […] Jan 30, 2026 - $EW
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple